|
Levocabastine Hydrochloride
4-Piperidinecarboxylic acid, 1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-, monohydrochloride, ()-[1(cis),3 ()-trans-1-[cis-4-Cyano-4-(p-fluorophenyl)cyclohexyl]-3-methyl-4-phenylisonipecotic acid monohydrochloride » Levocabastine Hydrochloride contains not less than 98.5 percent and not more than 101.5 percent of C26H29FN2O2·HCl, calculated on the dried basis.
Packaging and storage
Preserve in well-closed containers. Protect from light.
USP Reference standards
USP Levocabastine Hydrochloride RS .
USP Levocabastine Related Compound A RS.
Identification
A:
Infrared Absorption
B:
It meets the requirements of the tests for Chloride
C:
It meets the requirement for Specific rotation
Specific rotation
Test solution:
10 mg per mL, in methanol.
Loss on drying
Residue on ignition
Related compounds
[notePrepare solutions immediately before use.]
Diluent
Prepare an aqueous solution containing about 2 mg per mL of sodium hydroxide.
pH 9.0 Buffer
Dissolve about 1.39 g of boric acid in water, and adjust with 1 N sodium hydroxide to a pH of 9.0. Dilute with water to 100 mL.
Run buffer
Dissolve about 1.08 g of sodium dodecyl sulfate and about 650 mg of hydroxypropyl-
System suitability solution
Dissolve suitable quantities of USP Levocabastine Hydrochloride RS and USP Levocabastine Related Compound A RS in Diluent to obtain a solution containing about 0.0125 mg per mL of each compound.
Test solution
Transfer about 25 mg of Levocabastine Hydrochloride, accurately weighed, to a 10-mL volumetric flask, dissolve in and dilute with Diluent to volume, and mix.
Standard solution
Dilute 5.0 mL of the Test solution with Diluent to 100 mL. Dilute 1.0 mL of this solution with Diluent to 10 mL to obtain a solution containing about 0.0125 mg of levocabastine hydrochloride per mL.
System setup (see Capillary Electrophoresis
Procedure
Separately inject equal volumes (pressure of 3450 Pa for 5 seconds) of the Diluent (as the blank), the Standard solution, and the Test solution, and record the peak responses: the area for any peak in the Test solution, other than the major peak, is not greater than the major peak area obtained from the Standard solution (0.5%); and the sum of all peak areas in the Test solution, except for the major peak, is not greater than twice the major peak area obtained from the Standard solution (1.0%). Disregard any peak originating from the Diluent. Disregard any peak with an area of less than 0.1 times the major peak area obtained from the Standard solution (0.05%).
Assay
Dissolve about 175 mg of Levocabastine Hydrochloride, accurately weighed, in 50 mL of alcohol, and add 5.0 mL of 0.01 N hydrochloric acid. Titrate with 0.1 N sodium hydroxide VS, determining the endpoint potentiometrically. The volume of titrant required to titrate Levocabastine Hydrochloride is the difference between the first and third endpoints. Perform a blank determination, and make any necessary correction (see Titrimetry
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP32NF27 Page 2768
Pharmacopeial Forum: Volume No. 31(6) Page 1647
|